Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Netscientific Plc LSE:NSCI London Ordinary Share GB00B9F4MT28 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.125 -1.56% 7.875 4,427,096 16:17:13
Bid Price Offer Price High Price Low Price Open Price
7.50 8.25 8.375 7.25 8.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.74 -3.63 -5.70 6
Last Trade Time Trade Type Trade Size Trade Price Currency
16:28:56 O 1,000,000 12.00 GBX

Netscientific (NSCI) Latest News (2)

More Netscientific News
Netscientific Takeover Rumours

Netscientific (NSCI) Discussions and Chat

Netscientific Forums and Chat

Date Time Title Posts
06/8/202017:50NetScientific PLC2,365
04/8/202006:25NETSCIENTIFIC7
15/6/201911:31Netscientific16

Add a New Thread

Netscientific (NSCI) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-08-06 15:46:1412.001,000,000120,000.00O
2020-08-06 15:46:1412.001,000,000120,000.00O
2020-08-06 15:28:578.1425,8312,101.95O
2020-08-06 15:25:308.1515,0001,222.50O
2020-08-06 15:17:278.0952,2004,222.98O
View all Netscientific trades in real-time

Netscientific (NSCI) Top Chat Posts

DateSubject
06/8/2020
09:20
Netscientific Daily Update: Netscientific Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker NSCI. The last closing price for Netscientific was 8p.
Netscientific Plc has a 4 week average price of 4.60p and a 12 week average price of 4.60p.
The 1 year high share price is 18.50p while the 1 year low share price is currently 0.75p.
There are currently 78,561,866 shares in issue and the average daily traded volume is 7,227,232 shares. The market capitalisation of Netscientific Plc is £6,186,746.95.
06/8/2020
11:29
kingston78: It is common for AIM companies to raise fresh capital by way of a placing, which is quicker and cheaper than a rights issue. The placing price is always lower than the prevailing share price to attract investors. This does not necessarily mean that the share price will drift lower. I have seen instances where a well funded company after a placing goes on to succeed because it has the funds to invest. I hope this is the case with NSCI.
31/7/2020
10:21
kingston78: Short term sellers have taken profit and moved on. There is no follow up buys by existing holders, so the share price is now stagnant.
30/7/2020
11:02
kingston78: This is time for the share price to rise as it has dropped too much from its recent spike.
05/6/2020
07:26
investordave: Do we know when this news was released in the US? Was it after hours their time? Or pre closing, in which case it'll already be in the PDSB share price, which didn't change much?
16/4/2020
20:27
the stigologist: I don't think it is any surprise that We've had new Management (entrepreneurial Chatham House fellow Dr Iliev) Dr Iliev joins PDS Biotech Board PDS Announced change of strategy to target COVID19 I think the reason the NSCI share price looks like it might 'overshoot' fundamental value is that the market (and insiders) may think NSCI is now set to ADD VALUE to its holdings rather than be a passive investor. Glycotest seems to me to be the seriously big driver. Earlier NSCI Investor presentations suggested valuation potential for Glycotest of c.$400m IF (big IF) NSCI achieve that then their holding in Glycotest will be worth c.$200m Versus current NSCI Mkt Cap of £12m Many people have suggested ProAxsis might be a Covid play. It might be a secondary one. Could create some excitement. On that I'm yet to be convinced.
16/4/2020
17:50
learner9: Garth, Yes I agree. I think PDS Biotech looks undervalued at the moment and rise today so far has been muted, so I think it is worth a look at the current price. I am going to do some more reading on it. Not sure what caused the massive share price fall in March 18?. Never liked Netscientific as an investment . Like Woodford Patient Capital, they just seemed to throw money at bad biotech investments. Maybe with the management change they might get lucky with their current reduced portfolio but today's rise seems a bit crazy.
16/4/2020
14:14
w0lf0fwallstreet: Making medican for covid hmmmm and the share price is what
14/3/2019
14:54
bckttsim: Furthermore, the Company notes, that despite the increase in share price over recent days, the current share price still represents a substantial discount They are saying fill your boots it's cheap !
14/3/2019
09:45
saxxxon: Line two:Furthermore, the Company notes, that despite the increase in share price over recent days, the current share price still represents a substantial discount to the share price prior to announcing the update to the Strategic Review on 20 December 2018.
14/3/2019
08:48
letmepass: Furthermore, the Company notes, that despite the increase in share price over recent days, the current share price still represents a substantial discount to the share price prior to announcing the update to the Strategic Review on 20 December 2018.
Netscientific share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
NSCI
Netscienti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200807 05:18:00